Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:a meta-analysis

Gao Sheng; Liu JianYong; Zhang ZhiMing; Zhao YinNong; Yuan WeiPing; Wu FeiXiang; Xiang BangDe

doi:10.3969/j.issn.1001-5256.2014.09.020

Issue 9

Sep. 2014

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2014 > 30(9): 917-920

PDF( 1961 KB)

Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:a meta-analysis

DOI: 10.3969/j.issn.1001-5256.2014.09.020

Department of Hepatobiliary Surgery, Tumor Hospital of Guangxi Medical University

Research funding:

Received Date: 2013-12-30
Published Date: 2014-09-20

Abstract

Abstract

Objective To assess the efficacy of transcatheter arterial chemoembolization ( TACE) in patients with hepatocellular carcinoma ( HCC) before hepatectomy. Methods PubMed, Embase, the Cochrane Library, CNKI, VIP, and Wanfang Data were searched to identify randomized controlled trials ( RCTs) evaluating the efficacy of preoperative TACE plus hepatectomy ( study group) versus hepatectomy alone ( control group) in HCC patients published up to March 12, 2013. The quality of included studies was assessed, and relevant data were extracted. Statistical analysis was performed by RevMan 5. 2. Results A total of 4 RCTs involving 342 participants were included. Meta- analysis of data extracted from the included RCTs showed that there were no significant differences between the study group and control group in 1-, 3-, and 5- year disease- free survival ( DFS) , with relative risks ( RRs) ( 95% confidence intervals ( CIs) ) of 1. 07 ( 0. 92-1. 25) ( P = 0. 38) , 1. 05 ( 0. 79, 1. 41) ( P = 0. 72) , and 0. 95 ( 0. 64- 1. 42) ( P = 0. 81) , respectively, in 1-, 3-, and 5- year overall survival ( OS) , with RRs ( 95% CIs) of 1. 01 ( 0. 92- 1. 10) ( P = 0. 85) , 1. 14 ( 0. 97- 1. 34) ( P = 0. 11) , and 0. 95 ( 0. 75-1. 21) ( P = 0. 68) , respectively, and in rate of postoperative complications and mortality, with RRs ( 95% CIs) of 0. 89 ( 0. 45- 1. 75) ( P= 0. 73) and 0. 77 ( 0. 25- 2. 37) ( P = 0. 65) , respectively. Conclusion TACE before hepatectomy cannot increase DFS and OS and reduce complications and mortality in HCC patients. However, the numbers of studies and cases included in the analysis are small, and more high- quality, large- sample RCTs are needed to confirm the conclusion.
- carcinoma, hepatocellular,
- chemoembolization, therapeutic,
- hepatectomy,
- meta-analysis

FullText(HTML)

References(19)

References

[1]WU CC, HO YZ, HO WL, et al.Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma:a reappraisal[J].Br J Surg, 1995, 82 (1) :122-126.

[2]YAMASAKI S, HASEGAWA H, KINOSHITA H, et al.A prospective randomizedtrial of preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma[J].Jpn J Cancer Res, 1996, 87 (2) :206-211.

[3] ZHOU WP, LAI EC, LI AJ, et al.A prospective, randomized, controlled trial of preoperative transartefial chemoembolization for resectable large hepatocellular carcinoma[J].Ann Surg, 2009, 249 (2) :195-202.

[4] KAIBORI M, TANIGAWA N, KARIYA S, et al.A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma[J].Dig Dis Sci, 2012, 57 (5) :1404-1412.

[5] LLOVET JM, SCHWARTZ M, MAZZAFERRO V, et al.Resection and liver transplantation for hepatocellular carcinoma[J].Semin Liver Dis, 2005, 25 (2) :181-200.

[6] KOW AW, KWON CH, SONG S, et al.Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma:review of 1222 cases of hepatectomy in a tertiary institution[J].Ann Surg Oncol, 2012, 19 (7) :2246-2255.

[7] HO CM, WU CY, LEE PH, et al.Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma[J].Ann Surg Oncol, 2013, 20 (8) :2526-2533.

[8]BREEDIS C, YOUNG Y.The blood supply of neoplasms inthe liver[J].Am J Pathol, 1954, 30 (5) :969-977.

[9]WANG ZX, LI HQ, WANG ZT.The significance of surgery combined with interventional therapy in primary hepatic carcinoma[J].J Med Imaging, 2009, 19 (8) :987-989. (in Chinese) 王振旭, 李红旗, 王振亭.原发性肝癌外科手术联合血管内介入治疗的意义[J].医学影像学杂志, 2009, 19 (8) :987-989.

[10]PU J, WEI ZH, WANG JC, et al.The value of preoperative transcatherter arterial chemoembolization in reducing the lesion-residual rate after hepatecomy of primary hepatocellular carcinoma[J].J Pract Radiol, 2006, 22 (4) :446-452. (in Chinese) 浦涧, 韦忠恒, 汪建初, 等.术前肝动脉化疗栓塞对减少原发性肝癌手术癌残存的意义[J].实用放射学杂志, 2006, 22 (4) :446-452.

[11] SUGO H, FUTAGAWA S, BEPPU T, et al.Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma:relation between postoperative course and the pattern of tumor recurrence[J].World J Surg, 2003, 27 (12) :1295-1299.

[12]LU CD, PENG SY, JIANG XC, et al.Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas:retrospective analysis of 120 cases[J].World J Surg, 1999, 23 (3) :293-300.

[13]ZHANG B, WU LQ.Evaluation of treatment of primary liver cancer-transcatheter arterial chemoembolization before and after hepatectomy in treatment of primary liver cancer[J].Shangdong Med J, 2003, 43 (36) :56. (in Chinese) 张斌, 吴力群.肝切除术前后肝动脉置管化疗栓塞治疗原发性肝癌[J].山东医药, 2003, 43 (36) :56.

[14]YU WS, GUO RP, SHI M, et al.Efficacy of second stage resection following transcatheter hepatic arterial chemoembolization in patients with large hepatocellular carcinoma of hardly radical excision[J].J Sun Yat-Sen Univ:Medical Sciences, 2007, 28 (6) :709-713. (in Chinese) 俞武生, 郭荣平, 石明, 等.难以根治性切除大肝癌经皮肝动脉化疗栓塞术后二期切除的疗效分析[J].中山大学学报:医学科学版, 2007, 28 (6) :709-713.

[15]ZHOU JP, ZHOU WP, CONG WM, et al.Pathological study of resected specimens of resectable large hepatocellular carcinoma after transcatheter arterial chemoembolization[J].J Hepatobiliary Surg, 2004, 12 (1) :11-13. (in Chinese) 周建平, 周伟平, 丛文铭, 等.大肝癌TACE后手术切除标本的病理研究[J].肝胆外科杂志, 2004, 12 (1) :11-13.

[16]ZHU WB, LI CL, FANG XJ, et al.Preventive effects of perioperative transarterial chemoembolization on recurrence of large hepatocellular carcinoma[J].Chin J Hepatobiliary Surg, 2001, 7 (4) :208-230. (in Chinese) 朱玮冰, 李朝龙, 方学军, 等.围手术期肝动脉栓塞化疗预防大肝癌术后复发的作用初探[J].中华肝胆外科杂志, 2001, 7 (4) :208-230.

[17]LUO YQ, WANG Y, CHEN H, et al.Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma[J].Chin J Gen Surg, 2002, 17 (3) :149-151. (in Chinese) 罗运权, 王义, 陈汉, 等.可切除肝癌术前经肝动脉化学药物栓塞对肝切除手术的影响[J].中华普通外科杂志, 2002, 17 (3) :149-151.

[18] HARADA T, MATSUO K, INOUE T, et al.Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?[J].Ann Surg, 1996, 224 (1) :4-9.

[19]HUANG J, HE X, LIN X, et al.Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma[J].Chin Med J (Engl) , 2000, 113 (5) :446-448.引证本文:GAO S, LIU JY, ZHANG ZM, et al.Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:a meta-analysis[J].J Clin Hepatol, 2014, 30 (9) :917-920. (in Chinese) 高胜, 刘剑勇, 张志明, 等.肝细胞癌切除术前应用肝动脉化疗栓塞术疗效的Meta分析[J].临床肝胆病杂志, 2014, 30 (9) :917-920.

Relative Articles

[1]	Xiaoqing WANG, Jie LONG, Fei WANG, Zhexiong LIAN. Impact of cancer-associated fibroblasts on immunotherapy and liver metastasis in colorectal cancer[J]. Journal of Clinical Hepatology, 2024, 40(6): 1183-1190. doi: 10.12449/JCH240618
[2]	Rui ZHANG, Jinhong CHEN. Treatment strategy of non-radical surgical resection for colorectal cancer liver metastases[J]. Journal of Clinical Hepatology, 2024, 40(7): 1295-1300. doi: 10.12449/JCH240702
[3]	Chinese College of Surgeons, Chinese Medical Doctor Association, Chinese Society Gastrointestinal Surgery, Chinese Society of Surgery, Chinese Medical Association, Chinese Society of Colorectal Surgery, Chinese Society of Surgery, Chinese Medical Association, Section of Colorectal Oncology, Chinese Society of Oncology, Chinese Medical Association, Colorectal Cancer Professional Committee, Chinese Anti-Cancer Association, Colorectal Cancer Professional Committee, Chinese Medical Doctor Association, Colorectal Cancer Expert Committee, Chinese Society of Clinical Oncology, Chinese College of Colorectal Surgeons, Chinese College of Surgeons, Chinese Medical Doctor Association, Metastasis Research Committee, Anorectal Branch of Chinese Medical Doctor Association, Colorectal Liver Metastases Professional Committee, China International Exchange and Promotive Association for Medical and Health Care. China guideline for diagnosis and comprehensive treatment of colorectal liver metastases (2020 edition)[J]. Journal of Clinical Hepatology, 2021, 37(3): 543-553. doi: 10.3969/j.issn.1001-5256.2021.03.009
[4]	Xuemin LI, Hao WANG, Junjie WANG. Stereotactic ablative radiotherapy for colorectal cancer liver metastasis[J]. Journal of Clinical Hepatology, 2021, 37(3): 522-526. doi: 10.3969/j.issn.1001-5256.2021.03.006
[5]	Xiangqian HUANG, Xiaomeng YAN, Mingda ZHANG, Jing WU, Jianhong CHEN. Association between nonalcoholic fatty liver disease and colorectal neoplasms[J]. Journal of Clinical Hepatology, 2021, 37(12): 2947-2950. doi: 10.3969/j.issn.1001-5256.2021.12.045
[6]	Gao BenJian, Luo Jia, Liu Ying, Yang XiaoLi, Su Song, Li Bo. Efficacy and safety of laparoscopic versus open liver resection in treatment of colorectal cancer liver metastasis: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(3): 573-579. doi: 10.3969/j.issn.1001-5256.2020.03.021
[7]	Li Jiang, Hou Yu, Cai XiaoBei, Xu ChengLei, Yi GenFa. Clinical effect of local treatment based on limited segmental resection in improving the prognosis of liver oligometastasis after surgery for colorectal cancer[J]. Journal of Clinical Hepatology, 2020, 36(8): 1763-1767. doi: 10.3969/j.issn.1001-5256.2020.08.017
[8]	Liao Yang, Li ShengWei. Current status of associating liver partition and portal vein ligation for staged hepatectomy in treatment of liver metastasis of colorectal cancer[J]. Journal of Clinical Hepatology, 2019, 35(12): 2805-2808. doi: 10.3969/j.issn.1001-5256.2019.12.035
[9]	Liu SiFu, Xie ZhengYuan. Association between nonalcoholic fatty liver disease and colorectal tumors[J]. Journal of Clinical Hepatology, 2019, 35(9): 2091-2094. doi: 10.3969/j.issn.1001-5256.2019.09.046
[10]	Min YongFeng, Zhang Bo. Microwave ablation combined with 125I particle implantation in treatment of hepatic metastasis with diaphragm perforation: A case report[J]. Journal of Clinical Hepatology, 2018, 34(8): 1758-1759. doi: 10.3969/j.issn.1001-5256.2018.08.034
[11]	Li Hao, Duan XuHua, Han XinWei, Ren JianZhuang, Li FengYao, Kuang DongLin, Li FangZheng. Clinical effect of transarterial chemoembolization combined with radiofrequency ablation in treatment of rabbit VX2 liver tumors[J]. Journal of Clinical Hepatology, 2018, 34(4): 779-783. doi: 10.3969/j.issn.1001-5256.2018.04.017
[12]	Sun Wei, Ding XiaoYan, Chen JingLong, Li WenDong, Guo XiaoDi, Shen YanJun, Sun ShaSha, Teng Ying, Liu XiaoMin, Wei JianYing. Clinical effect and safety of radiofrequency ablation combined with systemic chemotherapy in treatment of unresectable or postoperative recurrent intrahepatic cholangiocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(8): 1717-1722. doi: 10.3969/j.issn.1001-5256.2018.08.025
[13]	Society for Minimally Invasive Surgery, Chinese Research Hospital Association. Technical guidelines for simultaneous laparoscopic and robotic resection of colorectal cancer with liver metastasis ( Revised in 2017)[J]. Journal of Clinical Hepatology, 2018, 34(3): 494-497. doi: 10.3969/j.issn.1001-5256.2018.03.007
[14]	An DongJun, An Lin, Zhang Cheng, Zhao WeiAn, Han Li. Efficacy of laparoscopic microwave ablation in treatment of malignant liver tumors[J]. Journal of Clinical Hepatology, 2017, 33(11): 2158-2161. doi: 10.3969/j.issn.1001-5256.2017.11.021
[15]	Song Li, Zou YingHua. Prevention and treatment of complications after radiofrequency ablation for hepatic tumors in high-risk locations[J]. Journal of Clinical Hepatology, 2017, 33(4): 647-650. doi: 10.3969/j.issn.1001-5256.2017.04.009
[16]	Lu NingNing, Sun Bin, Cui XiongWei, Long Jiang, Gao WenFeng, Zheng JiaSheng. Diagnosis and treatment of subcapsular hemorrhage after liver tumor ablation[J]. Journal of Clinical Hepatology, 2017, 33(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2017.12.014
[17]	Wang DongXu, Huo TingTing, Tian YaoWen, Zhao Lei. Current status of research on microRNA associated with colorectal cancer liver metastasis[J]. Journal of Clinical Hepatology, 2016, 32(12): 2387-2390. doi: 10.3969/j.issn.1001-5256.2016.12.034
[18]	Jian QianHong, Zheng FangRong, Yan Xiong. Current status of research on transcatheter arterial chemoembolization in treatment of colorectal cancer liver metastasis[J]. Journal of Clinical Hepatology, 2016, 32(6): 1216-1219. doi: 10.3969/j.issn.1001-5256.2016.06.047
[19]	Wang Xin, Zhang Hui, He XiaoJun, Li XinHui, Liu Yang, Zhang HongYi. Clinical effect of precise sequential interventional therapy in patients with unresectable hepatic metastasis after surgery for colorectal cancer[J]. Journal of Clinical Hepatology, 2016, 32(3): 518-521. doi: 10.3969/j.issn.1001-5256.2016.03.025
[20]	Zhang ZhiQuan. Analysis of prognostic factors for patients treated by radical resection of liver metastases from colorectal cancer[J]. Journal of Clinical Hepatology, 2015, 31(9): 1455-1457. doi: 10.3969/j.issn.1001-5256.2015.09.022

Supplements(0)

Cited By

Cited by

Periodical cited type(2)

1.	凌清儿，张戎. 肝纤维化治疗的研究进展. 现代医药卫生. 2023(11): 1926-1931 .
2.	揭阳，叶林茂，何怡，邵畅，孙希光，张俊杰. 基于IFN-γ/STAT1/Smad7通路探讨疏肝健脾活血方抗肝纤维化作用机制. 中华中医药杂志. 2023(09): 4136-4141 .

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2670) PDF downloads(612)

Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:a meta-analysis

DOI: 10.3969/j.issn.1001-5256.2014.09.020